MYC and cancer: Of 87 patients, 21 patients were analyzed by NGS with 48 selected cancer genes including GNA11, GNAQ and FBXW7, and 66 patients were analyzed for mutations by NGS with 592 cancer genes including BAP1 and SF3B1 mutations as well as MYC amplification (Supplement Table S1).